Alteration in cerebrospinal fluid (CSF) markers associated with α-synucleinopathies
- 22 November 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Archiv Fur Psychiatrie Und Nervenkrankheiten
- Vol. 271 (5), 999-1000
- https://doi.org/10.1007/s00406-020-01212-0
Abstract
Rapid eye movement sleep behavior disorder (RBD) is linked to other α-synucleinopathies such as Parkinson’s disease and Lewy body dementia. It is essential to consider and exclude RBD while studying CSF markers in the latter two to avoid confounding bias and improve test results’ specificity.This publication has 6 references indexed in Scilit:
- Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre studyBrain, 2019
- CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorderTranslational Neurodegeneration, 2018
- Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementiaArchiv Fur Psychiatrie Und Nervenkrankheiten, 2018
- Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathiesClinical Neurophysiology, 2018
- Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levelsBrain, 2017
- A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation studyMovement Disorders, 2012